Glenmark to launch DCGI-approved cancer drug in India
Glenmark Pharmaceuticals
on Monday said it will launch
cancer treatment
drug
zanubrutinib
in India following approval by the Drugs Controller General of India (
DCGI
).
Zanubrutinib will be marketed in India under the brand name
Brukinsa
.
It is the first and only Bruton's tyrosine kinase (BTK) inhibitor approved in India for the treatment of five distinct B-cell malignancies: chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom macroglobulinemia, mantle cell lymphoma, marginal zone lymphoma, and follicular lymphoma.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Bank Owned Properties For Sale In Larantuka (Prices May Surprise You)
Foreclosed Homes | Search ads
Search Now
Undo
"We look forward to bringing Brukinsa to India in the coming months as part of our ongoing partnership with BeiGene (now BeOne Medicines)," Glenmark Pharmaceuticals President and Business Head - India Formulations Alok Malik said.
The launch marks a significant milestone in our innovative oncology portfolio, offering patients in India access to a globally trusted therapy with proven efficacy and safety, he added. Glenmark shares on Monday ended 0.68 per cent up at Rs 1,600.85 apiece on BSE.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
18 minutes ago
- Time of India
US stock market today: S&P 500 flat, Dow Jones down, Nasdaq‑100 up— biggest gainers, losers as Wall Street eyes US-China trade talks and potential tariff deal
US stock market live update: Dow Jones drops 185 points as investors await US-China trade talks progress- The US stock market opened slightly weaker on Monday, June 9, as Wall Street turned its attention to critical trade talks between the United States and China. Early trading saw the Dow Jones Industrial Average fall by 185 points, or about 0.5%, marking a cautious start to the week. The S&P 500 dipped 0.1%, while the Nasdaq Composite edged up slightly by 0.1% around 9:35 a.m. Eastern Time. Traders are closely watching the developments in London, where senior officials from both countries are meeting to ease long-standing trade tensions. The discussions aim to address a range of economic disputes and possibly roll back mutual tariffs that have been weighing on global supply chains for years. How are the major indices performing? S&P 500 (SPY): Sitting steady at about 599.15, virtually unchanged from the previous close, remaining just under the 6,000 mark. Dow Jones Industrial Average (DIA): Dropping roughly 0.21% to 427.47, reflecting some investor caution. Nasdaq-100 (QQQ): Climbing around 0.16% to 530.77, fueled by strength in the tech sector. Which stocks are making the biggest moves? Top gainers today include: by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Here's What a New Roof Should Cost in 2025 Learn More Undo Warner Bros Discovery: Surging 7-9% following news of a company split. IonQ: Up about 3% after announcing an acquisition of Oxford Ionics. Merck: Rising 1.1%, boosted by positive trial results. Nvidia: Gaining between 1.3% and 2.3%, riding the wave of AI enthusiasm. Qualcomm: Jumping 4.4% on completion of its Alphawave IP purchase. Apple: Adding 0.7%, supported by new AI features unveiled at the WWDC event. Biggest losers include: Robinhood: Dropping 7.4% after being excluded from the S&P 500 index. Tesla: Down between 0.3% and 2%, impacted by a recent downgrade and fallout from Musk-related news. EchoStar: Falling 8.2% amid bankruptcy rumors. Live Events Why are the US and China meeting now — and what's at stake for the stock market? This week's US-China trade talks are seen as pivotal for the global economy. Tariffs imposed in past years have disrupted everything from electronics to heavy equipment. Though those tariffs are currently paused, no permanent deal has been reached. Analysts believe that progress in these talks could help avoid a potential economic slowdown or even a recession, especially if they result in the reduction or removal of tariffs on both sides. A positive outcome could also reignite investor confidence and fuel another leg up in the US stock market rally. These modest moves reflect investor hesitancy. Market players are clearly waiting for concrete news before making big decisions. The S&P 500 remains just 2.5% below its all-time high, buoyed by hopes that the US may reach trade agreements that roll back tariffs globally. What's driving the stock market recovery in 2025? One major factor behind the stock market's strong recovery has been the belief that President Donald Trump will reduce trade barriers as part of broader global deals. After plunging by nearly 20% from its peak two months ago, the S&P 500 has made a swift comeback. That optimism is largely driven by expectations that smoother trade relations — particularly with major economies like China — will relieve pressure on multinational companies and bring stability back to supply chains. Are tariffs still in effect, and why does it matter now? Currently, both the US and China have put a pause on new tariffs, but existing ones remain. These tariffs have cost industries billions, increased consumer prices, and created uncertainty for global manufacturers. What's important now is whether these paused tariffs are finally lifted. This could significantly improve the flow of goods, lower costs, and potentially lead to more business investments, especially in sectors like tech, agriculture, and manufacturing. Could US-China trade deals shape the next market trend? Absolutely. Any meaningful breakthrough in US-China trade negotiations could serve as a key catalyst for markets. Investors are looking for long-term clarity, not just temporary relief. If Monday's talks in London show signs of real progress, we could see increased investor confidence, reduced market volatility, and fresh momentum across Dow Jones, S&P 500, and Nasdaq. But without a deal, continued uncertainty could weigh on the markets in the coming weeks. What's driving the market today? Trade talks between the U.S. and China in London continue to shape investor sentiment, contributing to the Dow's decline and a slight Nasdaq boost. Inflation concerns remain front and center , with traders awaiting this week's CPI and core PCE data releases. Expectations suggest the Federal Reserve may hold interest rates steady for now. Sector trends show technology stocks powering the gains, while healthcare lags behind. What should investors watch next? Investors should keep a close eye on the statements or outcomes from the US-China meetings. Any mention of progress on tariff rollbacks, trade agreements, or economic cooperation could trigger immediate market reactions. It's also worth noting that the Federal Reserve's next move, broader economic indicators, and the 2024 US election climate remain in focus as secondary factors influencing the market direction. FAQs: Q1: Why did the Dow Jones fall 185 points today? The Dow Jones dropped due to investor caution ahead of the US-China trade talks. Q2: What are US-China trade talks about? The talks aim to ease tariffs and settle long-running trade disputes affecting the global economy.
Time of India
19 minutes ago
- Time of India
The healing power of Acupuncture: How wellness centres are reviving an ancient science
In a world dominated by modern medicine, where pills and surgeries often come with side effects and uncertainties, there is a powerful revival of traditional healing methods. And one such therapy is Acupuncture, which is slowly becoming a part and parcel of holistic health. What is Acupuncture? Acupuncture is a form of therapy in which very fine needles are inserted into specific points on the body, known as acupoints or marma points. It is believed that these tiny needles do not just physically stimulate, but also regulate the energy when they hit the marma points. Acupuncture works by correcting the imbalances in the marma points and the 'QI' of the body. And surprisingly, very few people know that there are more than 360 acupoints across the body, each linked to specific organs and functions, and stimulating these points helps in opening up blocked energy pathways, balancing body systems, and restoring harmony. Acupuncture offerings by Patanjali Patanjali Wellness, under the guidance of Acharya Balkrishna and Swami Ramdev, has integrated acupuncture into its wide range of natural healing therapies. Patanjali's acupuncture therapy is offered as part of its larger wellness ecosystem that includes Ayurveda , Panchakarma, naturopathy, yoga, and physiotherapy. And at Patanjali, there are 5 major types of Acupuncture techniques in play - Cupping method that uses suction cups to draw out toxins and stimulate circulation, Ear Acupuncture, which focuses on the ear as a micro-system of the whole body, Electro-Acupuncture, which is a mix of traditional needling with mild electrical currents, Moxibustion, where a herbal stick is burned close to the skin to warm and energise acupoints, and Scalp Acupuncture, where specific zones on the scalp are targeted. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo Each of these techniques is designed to address specific health concerns while also improving overall well-being. Benefits of Acupuncture Acupuncture is more than just needles, pain, slight bloodletting, and traditional therapy. It is a practice that helps restore the body's inner energy and helps with better function. And while most people think that Acupuncture is just needles and pain, it also has analgesic effects, where, by stimulating the nervous system, it increases the body's natural painkillers like endorphins and enkephalins, providing relief from chronic pain, migraines, joint pain, and more. Plus, Acupuncture is also believed to benefit the central nervous system, reducing harmful brainwaves and helping restore a state of calm and balance. It also supports the immune system by improving energy flow and blood circulation, and helps to enhance white blood cell activity, increasing antibody production, and balancing immune responses. One step to a healthier you—join Times Health+ Yoga and feel the change
Time of India
20 minutes ago
- Time of India
Good oil has its limits too: Why olive oil may be expanding your waistline, one fat cell at a time
Olive oil has long been hailed as a golden elixir of health, praised by Mediterranean diets and wellness gurus alike. But a new study has stirred the pot — and your salad dressing — by revealing a surprising link between olive oil and weight gain. Published in Cell Reports , the research claims that oleic acid, the dominant monounsaturated fat in olive oil, could actually fuel the growth of fat cells — and potentially, your waistline. Led by Michael Rudolph, assistant professor of biochemistry and physiology at the University of Oklahoma College of Medicine, the study dives into how different types of fats affect the body. And the findings are anything but bland. Meet the 'Fat Cell Soldiers' That Olive Oil Might Be Recruiting In a controlled study using mice, Rudolph and his team fed diets high in various fats — from coconut oil to soybean oil — to see how they impacted the body. But only one fat stood out: oleic acid. This compound, abundant in olive oil and processed foods, triggered an increase in the body's 'fat cell soldiers,' or precursor fat cells. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like A neuropatia tem atrapalhado sua rotina? Esse aparelho está ajudando os idosos a ter mais alivio A arte do herbalismo Undo According to Rudolph, oleic acid stimulates a protein called AKT2 while suppressing another called LXR, both of which regulate fat storage. The result? More fat cells ready to store dietary nutrients — and a greater capacity for weight gain. 'If the excess nutrients overtake the number of fat cells, obesity can occur,' Rudolph warned. 'That can then lead to cardiovascular disease or diabetes if not controlled.' iStock Olive oil may be slimming in moderation, but too much could expand your waistline. (Representational image: iStock) Don't Ditch Your Olive Oil Bottle Just Yet Before you throw your olive oil out with the bathwater, there's a crucial caveat. The researchers stress that real-world diets are more complex — no one eats isolated fats in a lab setting. Plus, olive oil still boasts numerous health benefits: it's rich in antioxidants, supports brain function, improves heart health, and has even been linked to reduced cancer and dementia risk. You Might Also Like: No supplements needed: Longevity doctor shares the one daily nutrient that could add years to your life The problem isn't olive oil itself — it's the quantity and context in which it's consumed. Diets dominated by ultra-processed foods rich in oleic acid could tilt the balance. 'Moderation is key,' Rudolph said. 'Relatively balanced levels of oleic acid seem to be beneficial, but higher and prolonged levels may be detrimental.' Olive Oil is Still the Good Guy — Just Not the Only Guy In a world obsessed with 'superfoods,' this study is a wake-up call that even healthy ingredients have their limits. Olive oil remains a nutritional powerhouse — but when consumed in excess or combined with unhealthy food habits, it might be helping your fat cells multiply behind the scenes. So, yes — drizzle that olive oil over your salad. Just don't drown in it. You Might Also Like: Stanford scientists reveal simple dinner hack to stay slim and it starts with what you eat first Olive oil is not always healthy: Here is what you are not being told, nutritionists warn Trying to lose weight? Expert says changing this morning habit can make a big difference
